ACCRETAMAB Trademark

Host cells for medical or clinical use; cells for medical use, namely, cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; cells for medical use, namely, transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; pharmaceuticals, namely, central nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors being pharmaceutical products for treatment of blood pressure, prophylactic for the treatment of asthma, antitussives and expectorants, stomachics and digestives for pharmaceutical purposes, antacids, hormones in the nature of pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis; pharmaceuticals, namely, corticosteroids for treatment of hypopituitarism, of congenital adrenal hyperplasia, of rheumatoid arthritis, of rheumatic fever, of crohn's disease, and of chronic active hepatitis; pharmaceuticals, namely, estrogen preparations and progesterone used as combined oral contraceptives, urinary antiseptics, analgesics, anti-itching agents; pharmaceuticals, namely, cataplasms being medical plasters for the treatment of bruises, lumbago and stiff shoulder; pharmaceuticals, namely, pharmaceutical preparations used to treat hair disorders, vitamin preparations, food enriching agents in the nature of vitamins for treating vitamin deficiencies, anti-coagulants, enzyme preparations for medical purposes for control of malabsorption and diarrhea, anti-cancer preparations, anti-sarcoma preparations, antibiotics and their preparations for the treatment of infectious diseases, antituberculotic agents, influenza vaccines, diphtheria vaccines, tetanus vaccines, gas gangrene vaccines, Japanese encephalitis vaccines, in vitro tetrodotoxines for medical use, antiprotozoals for the treatment of trichomoniasis and dermatophytosis, anthelmintics for the treatment of threadworm and toxoplasmaosis, naturally occurring drugs delivery agents in the form of capsules, liquids, powders, patches for treating peptic ulcers, charred drugs delivery agents in the form of capsules, liquids, powders, patches for treating peptic ulcers, moxa in the nature of cone or stick made of ground mugwort leaves for treating peptic ulcers; pharmaceuticals, namely, veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidian in chickens, and dysentery in pigs; pharmaceuticals, namely, germination controllers and plant rearing agents in the nature of herbicides, fungicides, insecticides, bactericides and rodenticides for domestic and agricultural use; pharmaceuticals, namely, antiseptics, pharmaceutical drugs in the nature of drug delivery agents in the form of coatings for tablets for the treatment of arteriosclerosis, oncostatic drugs in the nature of pharmaceutical products for the treatment for cancer, multienzyme digestants for pharmaceutical in vivo use, antifungal antibiotics for treating trichomoniasis and dermatophytosis, drugs in the nature of pharmaceutical products for the prevention and treatment of parkinsonism, minor tranquilizers, and anti anxiety agents; pharmaceuticals, namely, medicinal preparations for the treatment of the central nervous system, the respiratory tract and the cardiovascular system; pharmaceuticals, namely, anti-bacterial preparations in the nature of antibacterial substances for medical purposes, monolithic preparations in the nature of substances for medical purposes, medicinal preparations for the treatment of peptic ulcers, anti-inflammatory preparations, analgesic preparations, cephalosporin, cocarboxylase preparations, glutathione preparations in the nature of radioactive substances and nutritive substances for microorganisms for medical purposes, pharmaceutical preparations for improving the metabolism and the peripheral circulation, blood plasma in the nature of plasma substitutes and extracorporeal circulation flow improvement preparations, diuretic and anti-hypertensive preparations, in vitro diagnostic reagents for medical use, in vitro extra corporeal diagnostic reagents for medical use, in vitro x-ray contrast agents for medical use, in vitro diagnostic media for medical use, and pharmaceutical preparations for the treatment of insomnia and other sleep related diseases; all the foregoing pharmaceuticals and vaccines comprising monoclonal antibodies